Evidence map›Paper›PMID 27549789›Full record

ReviewCellular and molecular life sciences : CMLS2017

The role of Epac in the heart.

Takayuki Fujita, Masanari Umemura, Utako Yokoyama, Satoshi Okumura, Yoshihiro Ishikawa

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. The Impact ofViruses · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Heart Failure in Menopause: Treatment and New Approaches.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  15. Review
  16. Integration of Rap1 and Calcium Signaling.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Takayuki FujitaCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan. fujitaka@yokohama-cu.ac.jp.ORCID 0000-0002-6391-6126
Masanari UmemuraCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Utako YokoyamaCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satoshi OkumuraCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yoshihiro IshikawaCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan. yishikaw@med.yokohama-cu.ac.jp.
Cardiovascular Institute Hospital · JPTsurumi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As one of the most important second messengers, 3',5'-cyclic adenosine monophosphate (cAMP) mediates various extracellular signals including hormones and neurotransmitters, and induces appropriate responses in diverse types of cells. Since cAMP was formerly believed to transmit signals through only two direct target molecules, protein kinase A and the cyclic nucleotide-gated channel, the sensational discovery in 1998 of another novel direct effecter of cAMP [exchange proteins directly activated by cAMP (Epac)] attracted a great deal of scientific interest in cAMP signaling. Numerous studies on Epac have since disclosed its important functions in various tissues in the body. Recently, observations of genetically manipulated mice in various pathogenic models have begun to reveal the in vivo significance of previous in vitro or cellular-level findings. Here, we focused on the function of Epac in the heart. Accumulating evidence has revealed that both Epac1 and Epac2 play important roles in the structure and function of the heart under physiological and pathological conditions. Accordingly, developing the ability to regulate cAMP-mediated signaling through Epac may lead to remarkable new therapies for the treatment of cardiac diseases.

Indexed as

AnimalsApoptosisArrhythmias, CardiacCardiomegalyCyclic AMPGene ExpressionGuanine Nucleotide Exchange FactorsHeartHeart FailureHumansMyocardial ContractionMyocardiumMyocytes, CardiacCyclic AMPGuanine Nucleotide Exchange FactorsRAPGEF3 protein, humanRAPGEF4 protein, humancAMPCatecholamineEpacHeartHeart disease

Identifiers

PMID27549789
PMCPMC11107744
OpenAlexW2508912976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.